C12N 9/0053
Acting on a heme group of donors
Official title: {acting on a heme group of donors (1.9)}
C12N9/0053 (Acting on a heme group of donors) appears on 37 US grants and 56 published applications in this corpus.
Search patents in C12N- Granted patents
- 37
- Published applications
- 56
- Assignees
- 40
- Inventors
- 118
- Latest grant
- 5 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 3 |
| 2003 | 2 | 1 |
| 2004 | 0 | 5 |
| 2005 | 3 | 3 |
| 2006 | 1 | 4 |
| 2007 | 1 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 3 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 2 | 6 |
| 2016 | 0 | 1 |
| 2017 | 0 | 4 |
| 2018 | 2 | 3 |
| 2019 | 0 | 1 |
| 2020 | 2 | 1 |
| 2021 | 0 | 3 |
| 2022 | 1 | 3 |
| 2023 | 2 | 2 |
| 2024 | 1 | 4 |
| 2025 | 0 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures5 Mar 2024US 11,920,153 B2Alma Mater Studiorum - Università di Bologna
- Methods of improving cell-based therapy15 Aug 2023US 11,723,929 B2The Regents of the University of California
- Importation of mitochondrial protein by an enhanced allotopic approach18 Jul 2023US 11,702,671 B2Institut National De La Sante Et De La Recherche Medicale (Inserm)
- Compositions and methods for treating leber's hereditary optic neuropathy with NADH dehydrogenase proteins14 Jun 2022US 11,357,869 B2Wuhan Neurophth Biotechnology Limited Company
- L-threonine and L-tryptophan producing bacteria strain and method of making same29 Sep 2020US 10,787,692 B2Cj Cheiljedang Corporation
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures6 Aug 2026US 2026/0226408 A1Alma Mater Studiorum - Università di Bologna
- Applications of o2-insensitive formate dehydrogenase20 Nov 2025US 2025/0357519 A1University of Maryland, Baltimore
- Raav vector for the treatment of cox20 deficiency16 Oct 2025US 2025/0319209 A1University of Massachusetts
- Biosynthesis of oxygenated hydrocarbons6 Mar 2025US 2025/0075243 A1Ginkgo Bioworks, Inc.
- Compositions and methods for high efficiency genome editing24 Oct 2024US 2024/0350666 A1Children's Medical Center Corporation
Most cited
By later US patents
- Method of targeting conjugate molecules to mitochondria72US 6,171,859 B2MitoKor · 2001
- Cytochrome oxidase mutations aiding diagnosis of sporadic alzheimer's disease37US 5,565,323 AMitoKor · 1996
- Mitochondrial DNA mutations that segregate with late onset diabetes mellitus20US 5,840,493 AMitoKor · 1998
- Method for producing polypeptide via bacterial fermentation17US 5,342,763 AGenentech, Inc. · 1994
- Cellular models for diabetes and other diseases associated with mitochondrial defects17US 6,146,831 AMitoKor · 2000